A major week, for better or worse, for Alzheimer’s drug development. Read More
Related Articles
Bitcoin bombs lower, touching the dreaded $30,000 range
This is the web version of the Bull Sheet, Fortune’s no-BS daily newsletter on the markets. Sign up to receive it in your inbox here. Happy Friday, Bull Sheeters. A risk-off mood has descended over markets as COVID worries intensify. From Tokyo to Frankfurt, there’s red on the screens, and U.S. futures aren’t doing much better. […]
Friday Feedback: Stakeholder capitalism vs socialism
The best way to avoid hyper-regulation is for business to do a better job modulating its own behavior. Read More
WHO team investigating the origin of COVID-19 will enter China after delays
Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today. A team of scientists dispatched by the World Health Organization to investigate the origins of the COVID-19 outbreak in Wuhan will arrive in China on Thursday, the country’s National Health Commission said Monday—more than a […]